Phytor Ltd. is an Israel-based life sciences company providing laboratory services, drug development, and regulatory consulting, with a focus on oncology, neurodegenerative diseases, and naturally derived product solutions.
Phytor Ltd. is a biotechnology research company based in Jerusalem, Israel, that specializes in providing drug development, regulatory, and consulting services for the life sciences industry. The company operates a laboratory focused on biologically led assays and the synthesis of novel chemical entities derived from plant molecules. Their R&D activities include the development of therapeutics for oncology and neurodegenerative diseases, alongside the creation of diagnostic tools. By utilizing expertise in medicinal chemistry, pharmacology, toxicology, and regulatory compliance, Phytor assists partners in translating research from the bench to commercial applications in fields such as pharmaceuticals, dietary supplements, and food products.
The company serves as a contract research organization (CRO) for a diverse range of clients, offering outsourcing R&D and strategic regulatory support to ensure products meet market and safety standards. Phytor’s scientific team leverages state-of-the-art instrumentation to perform specialized analyses, including flow cytometry, chemical characterization, and cell-based assays. Their work has been applied to various collaborative projects, including the development of plant-based dietary supplements and novel antimicrobial agents, with their scientific contributions and research findings documented in peer-reviewed publications.